These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 1679332)
1. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. Kay TW; Campbell IL; Harrison LC J Autoimmun; 1991 Apr; 4(2):263-76. PubMed ID: 1679332 [TBL] [Abstract][Full Text] [Related]
2. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes. Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593 [TBL] [Abstract][Full Text] [Related]
4. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related]
5. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes. Redd S; Ginn S; Ross JM Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794 [TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide. Reddy S; Yip S; Karanam M; Poole CA; Ross JM Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865 [TBL] [Abstract][Full Text] [Related]
7. Morphological analysis of selective destruction of pancreatic beta-cells by cytotoxic T lymphocytes in NOD mice. Hayakawa M; Yokono K; Nagata M; Hatamori N; Ogawa W; Miki A; Mizoguti H; Baba S Diabetes; 1991 Sep; 40(9):1210-7. PubMed ID: 1682198 [TBL] [Abstract][Full Text] [Related]
8. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants. Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257 [TBL] [Abstract][Full Text] [Related]
9. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells. Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884 [TBL] [Abstract][Full Text] [Related]
10. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. Goldrath AW; Barber L; Chen KE; Alters SE J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149 [TBL] [Abstract][Full Text] [Related]
11. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Ablamunits V; Elias D; Cohen IR Clin Exp Immunol; 1999 Feb; 115(2):260-7. PubMed ID: 9933451 [TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161 [TBL] [Abstract][Full Text] [Related]
13. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Reddy S; Wu D; Swinney C; Elliott RB Pancreas; 1995 Jul; 11(1):16-25. PubMed ID: 7667242 [TBL] [Abstract][Full Text] [Related]
15. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321 [TBL] [Abstract][Full Text] [Related]
16. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igμ(null) mice after polyclonal B cell reconstitution. Vong AM; Daneshjou N; Norori PY; Sheng H; Braciak TA; Sercarz EE; Gabaglia CR J Transl Med; 2011 Jul; 9():101. PubMed ID: 21722394 [TBL] [Abstract][Full Text] [Related]
17. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Mellanby RJ; Thomas D; Phillips JM; Cooke A Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252 [TBL] [Abstract][Full Text] [Related]
18. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452 [TBL] [Abstract][Full Text] [Related]
19. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. Greeley SA; Moore DJ; Noorchashm H; Noto LE; Rostami SY; Schlachterman A; Song HK; Koeberlein B; Barker CF; Naji A J Immunol; 2001 Oct; 167(8):4351-7. PubMed ID: 11591759 [TBL] [Abstract][Full Text] [Related]